Aligos Therapeutics Inc. – Filings and Transcripts

NASDAQ: ALGS
Share price (6/23/26): $5.65
Market cap (6/23/26): $35.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Registration of securities for employees

Ownership Filter

Woodline Partners LP

Symons Julian A.

Calhoun Lesley Ann

News Filter

Reports Recent Business Progress and First Quarter 2026 Financial Results

Material Definitive Agreement

Announces First Interim Analysis Results From the Phase 2 B-Supreme Study of Pevifoscorvir Sodium in Participants With Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation

Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC